Skip to main content
Erschienen in: Drugs 15/2001

01.12.2001 | Adis New Formulation Profile

Cetirizine/Pseudoephedrine

A Viewpoint by K. Kontou-Fili

verfasst von: K. Kontou-Fili

Erschienen in: Drugs | Ausgabe 15/2001

Einloggen, um Zugang zu erhalten

Excerpt

Cetirizine 5mg in combination with pseudoephedrine hydrochloride sustained-release 120mg was developed in order to provide more efficient and prompt relief of rhinitis symptoms. Double-blind, placebo-controlled clinical trials involving close to 900 patients experiencing seasonal or perennial allergic rhinitis have demonstrated that cetirizine plus pseudoephedrine controls most naso-ocular symptoms to a greater extent than either component alone; nasal congestion, a symptom usually unaffected by antihistamine H1 antagonists alone, was significantly reduced in patients with perennial allergic rhinitis. …
Literatur
1.
Zurück zum Zitat Torfs CP, Katz EA, Bateson TF, et al. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology 1996; 54: 84–92PubMedCrossRef Torfs CP, Katz EA, Bateson TF, et al. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology 1996; 54: 84–92PubMedCrossRef
2.
Zurück zum Zitat Werler MM, Mitchell AA, Shapiro S. First trimester maternal medication use in relation to gastroschisis. Teratology 1992; 45: 361–7PubMedCrossRef Werler MM, Mitchell AA, Shapiro S. First trimester maternal medication use in relation to gastroschisis. Teratology 1992; 45: 361–7PubMedCrossRef
Metadaten
Titel
Cetirizine/Pseudoephedrine
A Viewpoint by K. Kontou-Fili
verfasst von
K. Kontou-Fili
Publikationsdatum
01.12.2001
Verlag
Springer International Publishing
Erschienen in
Drugs / Ausgabe 15/2001
Print ISSN: 0012-6667
Elektronische ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200161150-00011

Weitere Artikel der Ausgabe 15/2001

Drugs 15/2001 Zur Ausgabe

Adis Drug Evaluation

Rabeprazole

Adis New Formulation Profile

Cetirizine/Pseudoephedrine

Adis Drug Evaluation

Peginterferon-α-2a (40kD)

Adis New Formulation Profile

Once-Weekly Fluoxetine

Adis Drug Evaluation

Capecitabine